Welcome to our Aesthetic Medicine news roundup, 03 December 2021.
News Roundup
TikTok star Dr Daniel Aronov banned by regulator from performing cosmetic surgery
A senior associate of the controversial clinic owner Dr Daniel Lanzer has been banned by the national health regulator from performing all types of cosmetic surgery and ordered to remove his social media posts.
Cosmetic surgery ads to be banned for under-18s
Adverts for cosmetic surgeries designed to change a person’s physical appearance are to be banned from targeting under-18s. The UK advertising watchdog says the rules will come into force from May next year.
UK cracks down on teen plastic surgery
In an apparent bid to enhance teenagers’ and children’s self-esteem, a UK regulator has announced it will soon ban the promotion of body upgrades to these age groups.
A perspective on the role of media in cosmetic medicine
At this point in the pandemic, most people have used a front-facing video chatting app to connect with colleagues, friends, and family. Many of us have probably also looked at our screens and noticed the gray hairs, the frown lines, and the blemishes.
Plastic Surgery Isn’t Taboo Anymore – Celebs are finally talking about their new faces.
A few months ago, I had a lower-face and neck lift. Before the surgery, a nurse called to give me a list of what to bring for my two-night recovery in a hotel. Along with a baby toothbrush and arnica tablets, she said, “Don’t forget a headscarf and sunglasses so no one will recognize you.” I politely declined. First of all, since I’m a noncelebrity, no one would care.
Silk Medical Aesthetics Announces Feasibility Clinical Trial Results for its All-Natural Dermal Filler
Silk Medical Aesthetics has created a next-generation dermal filler with lidocaine by enhancing the best features of hyaluronic acid with Activated Silk™ biotechnology. Promising safety and effectiveness results are available from the ongoing feasibility study in the nasolabial folds – and the filler is now being expanded into lips with FDA Approval to initiate a second feasibility study.
AMP
